Form CORRESP - Correspondence:
SEC Accession No. 0001104659-15-068918
Filing Date
2015-10-02
Accepted
2015-10-02 17:01:52
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 21306
2 GRAPHIC g81567bgi001.jpg GRAPHIC 3016
  Complete submission text file 0001104659-15-068918.txt   26491
Mailing Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355
Business Address SUITE 400, 101 LINDENWOOD DRIVE MALVERN PA 19355 484-321-5554
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

EIN.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations